BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials. In addition, it manufactures ultra pure chitosans under the Ultrasan name; and offers manufacturing and analytical services. The company was incorporated in 1994 and is based in Laval, Canada. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. Biosyntech Inc. is in reorganization.

CEO

Dr. Amine Selmani Ph.D.

Country

Listings

0 Comments

Share your thoughts

FAQ

What is BIOSYNTECH INC stock price today?▼

The current price of BSYI is $0 USD — it has decreased by -99.67% in the past 24 hours. Watch BIOSYNTECH INC stock price performance more closely on the chart.

What is BIOSYNTECH INC stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange BIOSYNTECH INC stocks are traded under the ticker BSYI.

Is BIOSYNTECH INC stock price growing?▼

BSYI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year BIOSYNTECH INC has showed a +0% increase.

In which sector is BIOSYNTECH INC located?▼

BIOSYNTECH INC operates in the Health Care sector.

When did BIOSYNTECH INC complete a stock split?▼

BIOSYNTECH INC has not had any recent stock splits.

Where is BIOSYNTECH INC headquartered?▼

BIOSYNTECH INC is headquartered in Laval, CA.